Repligen
RGEN
#2045
Rank
ยฃ6.96 B
Marketcap
ยฃ123.76
Share price
-0.47%
Change (1 day)
11.00%
Change (1 year)
Categories

Revenue for Repligen (RGEN)

Revenue in 2025 (TTM): ยฃ0.53 Billion

According to Repligen 's latest financial reports the company's current revenue (TTM ) is ยฃ0.53 Billion. In 2024 the company made a revenue of ยฃ0.50 Billion an increase over the revenue in the year 2023 that were of ยฃ0.48 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Repligen from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.53 B6.36%
2024 ยฃ0.50 B3.64%
2023 ยฃ0.48 B-26.37%
2022 ยฃ0.66 B33.37%
2021 ยฃ0.49 B84.87%
2020 ยฃ0.26 B30.38%
2019 ยฃ0.20 B34.82%
2018 ยฃ0.15 B46.27%
2017 ยฃ0.10 B23.35%
2016 ยฃ84.72 M50.3%
2015 ยฃ56.37 M38.1%
2014 ยฃ40.81 M-1.23%
2013 ยฃ41.32 M7.28%
2012 ยฃ38.52 M
2010 ยฃ17 M33.01%
2009 ยฃ12.78 M-33.23%
2008 ยฃ19.15 M93.18%
2007 ยฃ9.91 M46.43%
2006 ยฃ6.76 M-10.34%
2005 ยฃ7.55 M70.96%
2004 ยฃ4.41 M15.36%
2003 ยฃ3.82 M-15.29%
2002 ยฃ4.51 M80.47%
2001 ยฃ2.5 M39.6%
2000 ยฃ1.79 M-15.78%
1999 ยฃ2.12 M47.57%
1998 ยฃ1.44 M-18.24%
1997 ยฃ1.76 M-20.45%
1996 ยฃ2.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novavax
NVAX
ยฃ0.76 B 44.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ2.32 B 337.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ2.01 B 278.97%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ32.96 B 6,108.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ32.80 B 6,078.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.03 B 6,685.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.10 B 8,769.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.91 B 71.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ24.66 M-95.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ3.01 B 468.41%๐Ÿ‡บ๐Ÿ‡ธ USA